Ponsus Pharma attending ADD

Published on Wednesday, 27 January 2010 00:00

Ponsus Pharma will be attending 68th Annual Meeting of the American Academy of Dermatology in Miami 5-9th of March

STOCKHOLM, Jan. 29. Ponsus Pharma will be attending the AAD in March and is looking for out licensing products based on its Proderm Technology. Ponsus Pharma AB develops high performing dermatological products based on their patented Proderm Technology for pharmaceutical and cosmeceutical companies, targeting the fast moving Consumer Goods market. The water-lipid nature of the Proderm Technology allows ingredients to be rapidly absorbed and incorporated into the outer layers of the skin. Furthermore, Proderm Technology is non-comedogenic and provides a cosmetically elegant feel in addition to ease of application because it is non-greasy and spreads easily. Unlike some topical foam preparations, Proderm Technology does not use either alcohol or other organic solvents, therefore it is well tolerated by patients. Ponsus Pharma markets their products mainly through a group of marketing partners in various countries.

For further information contact:
Lars Blak at: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Phone +46 8 511 88840
Fax +46 8 511 88841